Commitment to achieving net zero


Genmed is committed to achieving net zero emissions by 2045, in its own operations and working with our supply chain. To stay on track, we review our emissions and have set clear goals.
Draft plan subject to internal review for continuous improvement.
Near term goals (by 2030, 2022-2023 baseline)
Reduce Scope 1 by 5%
Reduce Scope 2 by 10%
Reduce Scope 3 by 45%

Picture1-1

Picture2-1


Long term goals (by 2050, 2022-2023 baseline)
Reduce Scope 1 by 50%
Reduce Scope 2 by 50%
Reduce Scope 3 by 75%

Picture3

Picture4

 

Picture5

Baseline emissions footprint


Baseline emissions are a record of the greenhouse gases that have been produced in the past and were produced prior to the introduction of any strategies to reduce emissions.
Baseline emissions are the reference point against which emissions reduction can be measured.
Baseline year: 2022-23
Additional details relating to the baseline emissions calculations:
Details of the standard, protocol, or methodology you have used to collect activity data and calculate emissions:
Genmed were awarded the ISO 14001:2015 certification in March 2020 and successfully retained the certification in 2023-2024 with zero major or minor nonconformities.
This means that Genmed maintain awareness of and comply with appropriate environmental legislation, regulations and accepted standards and codes of practice and fully meet customer and interested parties stated and/or perceived environmental expectations by the prevention of pollution as far as reasonably practicable. We look to continually review and monitor all aspects of the company’s activities in a bid to identify opportunities for implementing environmental performance improvement. Genmed ensure that this policy and supporting processes are understood by and communicated within the organisation and that this policy is available to the public.
In the year 2022-2023 we, measured all aspects within the office where we feel that we can reduce our environmental impact.
Reducing the amount of waste that we have going to landfill and have diverted over 80% of office waste going to landfill through our Biffa contract in our base year 2022-2023.
Introduced confidential shredding for all paper within the offices, and this is weighed and logged within the business. Each office uses local companies for their confidential shredding.

In our registered office in Wales, we have solar panels, and a ZIP tap which allows us to use only the water necessary.

Our electrical goods are collected and disposed of under WEEE regulations or, if possible, are recycled and reused internally. This includes mobile phones, screens, and laptops.

Supplier engagement 

Genmed conduct due diligence on all suppliers to allow us to have a full overview of all the companies who would have upstream and downstream impacts on the contract. We complete the vetting biannually and this due diligence includes the following:

 

  • Declaration from our suppliers that in the past 3 years have not had any breach of environmental, social, or labour law obligations and if they have, they are required to provide details.
  • Companies confirm that they abide by Modern Slavery act 2015 and the criminal law amendment bill 2015.
  • Companies to confirm if they hold a 14001 ISO certification or equivalent and are committed to social responsibility and work in communities


Base year footprint (002)

Current year Footprint

Emissions reduction targets

To continue our progress to achieving net zero, we have adopted the following carbon reduction targets.

We project that carbon emissions will decrease over the next five years to 33,227 tCO2e by 2030. This is a reduction of 35%.

 

Carbon reduction projects

Completed carbon reduction initiatives.

The following environmental management measures and projects have been completed or implemented since the 2022-2023 baseline. The carbon emission reduction achieved by these schemes equate to 27,032 tCO2e, a 34.59% reduction against the 2022-2023 baseline and the measures will be in effect when performing the contract.

The following projects were initiated by Genmed in 2023-2024 to reduce emissions as 69% of Genmed’s total emissions are scope 3 our focus is on Scope 3 sources.

 

Scope

Details

Activity

Outcome

3

Materials

Green Office Practices & procurement

Paperless workflows and digital documentation.

Double-sided printing and recycled paper use.

Office-wide recycling stations for paper, plastics.

Purchasing from eco-certified suppliers.

Using refillable or biodegradable office supplies

Reduction of total footprint reduction in scope 3 Materials by 65%

3

Travel

Sustainable Commuting – increased emphasis on using.

public transport, cycling, or carpooling.

Reduction of total footprint reduction in scope 3 Travel by 44%

 

Future carbon reduction initiatives

 

In the future we hope to implement further measures such as: Steering working group to review the companies ESG strategy in line with the UN 17 Sustainability goals. Further focus on scope 3 emissions with 3 key focus areas Waste, materials, and travel

 

Emission Reduction Targets

 

 

Scope

Details

Activity

3

Waste

Office-wide recycling stations for paper, plastics.

Programme of digitising documents and confidential shredding

3

Materials

Green Office Practices & procurement

Paperless workflows and digital documentation.

Using refillable or biodegradable office supplies

3

Travel

Sustainable Commuting – increased emphasis on using.

public transport, cycling, or carpooling.

 

Declaration and sign off.

This Carbon Reduction Plan has been completed in accordance with PPN 006 and associated guidance and reporting standard for Carbon Reduction Plans.

Emissions have been reported and recorded in accordance with the published reporting standard for Carbon Reduction Plans and the GHG Reporting Protocol corporate standard13 and uses the appropriate government emission conversion factors for greenhouse gas company reporting.14

Scope 1 and Scope 2 emissions have been reported in accordance with SECR requirements (where required), and the required subset of Scope 3 emissions have been reported in accordance with the published reporting standard for Carbon Reduction Plans and the Corporate Value Chain (Scope 3) Standard.15

This Carbon Reduction Plan has been reviewed and signed off by the board of directors (or equivalent management body) of Genmed.me Limited, a company registered in England and Wales with a company number of 06045647 

For all our current vacancies please visit the Genmed LinkedIn page.